A new risk score can help predict which pancreatic cancer survivors are more likely to suffer a recurrence of their cancer, ...
Pancreatic cancer accounts for about 8% of all cancer deaths. Ben Sasse says he expects to be one of them. Here's what to ...
TipRanks on MSN
Revolution Medicines advances daraxonrasib into phase 3 pancreatic cancer trial, extending long-term upside potential
Revolution Medicines, Inc. ($RVMD) announced an update on their ongoing clinical study. Study Overview Revolution Medicines, Inc. is running a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with obesity who underwent bariatric surgery had ...
Patients with pancreatic cancer who received chemotherapy both before and after surgery experienced longer survival rates than would be expected from surgery followed by chemotherapy, according to a ...
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit Looks Back at Pancreatic Cancer in 2025: A Year of Progress, ...
Doctors say Marie Fundora is much more than a master of fundraising over a glass of wine and a plate of Spaghetti Cardonara ...
In a randomized trial of patients with left-sided resectable pancreatic cancer, minimally invasive pancreatectomy showed comparable overall survival and disease-free survival to open surgery, ...
Metabolic-bariatric surgery (MBS) appears to lower the risk for pancreatic cancer in people with obesity, with a potentially greater effect in those who also have type 2 diabetes (T2D), new research ...
Pancreatic cysts are fluid-filled sacs that can form in the pancreas. Some remain benign, while others have the potential to develop into pancreatic cancer. A recent study, which followed 257 patients ...
Stage 2 pancreatic cancer includes stages 2A and 2B. Stage 2A is when the cancer tumor has grown to over 4 centimeters (cm). Stage 2B is when it has spread from the pancreas to up to three nearby ...
News Medical on MSN
New risk score helps predict pancreatic cancer recurrence
Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results